91 related articles for article (PubMed ID: 856712)
1. Inhibition studies on Vibrio cholerae neuraminidase.
Brossmer R; Keilich G; Ziegler D
Hoppe Seylers Z Physiol Chem; 1977 Mar; 358(3):391-6. PubMed ID: 856712
[TBL] [Abstract][Full Text] [Related]
2. A strategy for neuraminidase inhibitors using mechanism-based labeling information.
Hinou H; Miyoshi R; Takasu Y; Kai H; Kurogochi M; Arioka S; Gao XD; Miura N; Fujitani N; Omoto S; Yoshinaga T; Fujiwara T; Noshi T; Togame H; Takemoto H; Nishimura S
Chem Asian J; 2011 Apr; 6(4):1048-56. PubMed ID: 21305698
[TBL] [Abstract][Full Text] [Related]
3. An efficient approach to N-acetyl-D-glucosaminuronic acid-based sialylmimetics as potential sialidase inhibitors.
Mann MC; Thomson RJ; von Itzstein M
Bioorg Med Chem Lett; 2004 Nov; 14(22):5555-8. PubMed ID: 15482923
[TBL] [Abstract][Full Text] [Related]
4. Prenylated pterocarpans as bacterial neuraminidase inhibitors.
Nguyen PH; Nguyen TN; Kang KW; Ndinteh DT; Mbafor JT; Kim YR; Oh WK
Bioorg Med Chem; 2010 May; 18(9):3335-44. PubMed ID: 20363636
[TBL] [Abstract][Full Text] [Related]
5. Kinetic studies on the acid hydrolysis of the methyl ketoside of unsubstituted and O-acetylated N-acetylneuraminic acid.
Neuberger A; Ratcliffe WA
Biochem J; 1973 Aug; 133(4):623-8. PubMed ID: 4748825
[TBL] [Abstract][Full Text] [Related]
6. Selective isolation of Vibrio cholerae neuraminidase using an immobilized 4-(nitrophenyl)oxamic acid.
Brossmer R; Ziegler D; Keilich G
Hoppe Seylers Z Physiol Chem; 1977 Mar; 358(3):397-400. PubMed ID: 852823
[TBL] [Abstract][Full Text] [Related]
7. One-bead-one-inhibitor-one-substrate screening of neuraminidase activity.
Ying L; Gervay-Hague J
Chembiochem; 2005 Oct; 6(10):1857-65. PubMed ID: 16149103
[TBL] [Abstract][Full Text] [Related]
8. Use of conformationally restricted pyridinium alpha-D-N-acetylneuraminides to probe specificity in bacterial and viral sialidases.
Watson JN; Knoll TL; Chen JH; Chou DT; Borgford TJ; Bennet AJ
Biochem Cell Biol; 2005 Apr; 83(2):115-22. PubMed ID: 15864320
[TBL] [Abstract][Full Text] [Related]
9. [Enzymatic properties of neuraminidase from corynebacterium diptherial].
Khorlin IIa; Vertiev VV; Ezepchuk IaM; Privalova IM; Kvaratskheliia LD
Biokhimiia; 1975; 40(4):819-23. PubMed ID: 812557
[TBL] [Abstract][Full Text] [Related]
10. Characteristic of neuraminidase inhibitory xanthones from Cudrania tricuspidata.
Ryu YB; Curtis-Long MJ; Lee JW; Kim JH; Kim JY; Kang KY; Lee WS; Park KH
Bioorg Med Chem; 2009 Apr; 17(7):2744-50. PubMed ID: 19285413
[TBL] [Abstract][Full Text] [Related]
11. Contribution to the standardization of influenza neuraminidase inhibition tests, based on enzyme- antienzyme kinetic studies.
Siekmann U; Schoop HJ; Kuwert E
Dev Biol Stand; 1975; 28():324-35. PubMed ID: 1126576
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis and properties of an affinity adsorbent for purifying neuraminidases of varying origins].
Poltorak AN; Martiushin SV; Pasechnik VA
Prikl Biokhim Mikrobiol; 1985; 21(3):365-71. PubMed ID: 2864684
[TBL] [Abstract][Full Text] [Related]
13. A simple synthesis of N-perfluoroacylated and N-acylated glycals of neuraminic acid with a cyclic aminic substituent at the 4α position as possible inhibitors of sialidases.
Rota P; Allevi P; Agnolin IS; Mattina R; Papini N; Anastasia M
Org Biomol Chem; 2012 Apr; 10(14):2885-94. PubMed ID: 22395901
[TBL] [Abstract][Full Text] [Related]
14. [Reduction of the biological activity of Vibrio cholerae culture filtrates exposed to neuraminidase inhibitors].
Durikhin KV
Biull Eksp Biol Med; 1976; 81(4):452-4. PubMed ID: 1276448
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Vibrio cholerae neuraminidase by a novel mechanism-based fluorescent labeling reagent.
Hinou H; Kurogochi M; Shimizu H; Nishimura S
Biochemistry; 2005 Sep; 44(35):11669-75. PubMed ID: 16128567
[TBL] [Abstract][Full Text] [Related]
16. [2-Deoxy-2,3-dehydrosialic acids. II. Competitive inhibition of Vibrio cholerae neuraminidase by 2-deoxy-2,3-dehydro-N-acylneuraminic acids].
Meindl P; Tuppy H
Hoppe Seylers Z Physiol Chem; 1969 Sep; 350(9):1088-92. PubMed ID: 5349377
[No Abstract] [Full Text] [Related]
17. Transition state analysis of Vibrio cholerae sialidase-catalyzed hydrolyses of natural substrate analogues.
Chan J; Lewis AR; Indurugalla D; Schur M; Wakarchuk W; Bennet AJ
J Am Chem Soc; 2012 Feb; 134(8):3748-57. PubMed ID: 22296330
[TBL] [Abstract][Full Text] [Related]
18. Saturation transfer difference (STD) 1H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase.
Haselhorst T; Wilson JC; Thomson RJ; McAtamney S; Menting JG; Coppel RL; von Itzstein M
Proteins; 2004 Aug; 56(2):346-53. PubMed ID: 15211517
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.
Bossart-Whitaker P; Carson M; Babu YS; Smith CD; Laver WG; Air GM
J Mol Biol; 1993 Aug; 232(4):1069-83. PubMed ID: 8371267
[TBL] [Abstract][Full Text] [Related]
20. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
Levin Perlman S; Jordan M; Brossmer R; Greengard O; Moscona A
Virology; 1999 Dec; 265(1):57-65. PubMed ID: 10603317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
